Stock Market Media

  • Home
  • Stock Market Media

Stock Market Media News & media IR firm focused on shaping and publishing 100s of great stories every year in the financial markets that inform current shareholders while attracting new retail and institutional investors.

Stock Market Media Group is a content rich investor relations firm offering CEO's the platform to tell their company's story in the media. We provide Feature News Articles, Corporate Videos, Research Reports, and CEO Interviews that help publicly traded companies inform current and potential new shareholders in the Market.

SPYR Technologies Appoints Renowned International Technology, Media & Telecommunications Attorney John P. Formichella to...
02/11/2020
SPYR Technologies Appoints Renowned International Technology, Media & Telecommunications Attorney John P. Formichella to Board of Directors

SPYR Technologies Appoints Renowned International Technology, Media & Telecommunications Attorney John P. Formichella to Board of Directors

Mr. Formichella is a U.S. trained attorney and a leading expert in the Technology, Media& Telecommunications sector. Mr. Formichella has also served as an advisor to local chambers of commerce and US Embassies in Thailand and Taiwan, and governmental bodies regarding Technology, Media& Telecommunica...

SPYR Technologies Enters Apple HomeKit-Enabled Devices Market with Acquisition of IoT Technology Company
21/10/2020
SPYR Technologies Enters Apple HomeKit-Enabled Devices Market with Acquisition of IoT Technology Company

SPYR Technologies Enters Apple HomeKit-Enabled Devices Market with Acquisition of IoT Technology Company

Denver, CO - (NewMediaWire) - October 21, 2020 - SPYR Technologies, Inc. (OTC Pink: SPYR), a holding company involved in building a portfolio of technology companies through targeted acquisitions, today announced that it has acquired Applied MagiX Inc., a registered Apple developer, and reseller of....

SPYR Technologies Announces $15 Million Financing
12/10/2020
SPYR Technologies Announces $15 Million Financing

SPYR Technologies Announces $15 Million Financing

Denver, CO - (NewMediaWire) - October 12, 2020 - SPYR Technologies (OTC Pink: SPYR), a holding company involved in building a portfolio of technology companies through targeted acquisitions, today announced that it has secured $15 million in funding commitments for acquisitions and corporate expansi...

SPYR, Inc. Begins Operating Under the Trade Name SPYR Technologies
07/10/2020
SPYR, Inc. Begins Operating Under the Trade Name SPYR Technologies

SPYR, Inc. Begins Operating Under the Trade Name SPYR Technologies

--via NewMediaWire-- SPYR, Inc., a holding company involved in building a portfolio of technology companies through targeted acquisitions, today announced that it has filed a trade name in order to do business as SPYR Technologies effective immediately.. SPYR President and Chief Executive Officer, J...

14/08/2020

$SPYR undergoing accumulation and the price is responding. Low float stock that has seen $1+ several times, so could it be heading there again?

Join 1000s who already get our content delivered directly to their inbox--be the first to know what's in play.
08/08/2020
Stock Market Media Group

Join 1000s who already get our content delivered directly to their inbox--be the first to know what's in play.

Stock Market Media Group Email Forms

Great News!! Should be the last piece of business before filing the IND. >> PharmaCyte Biotech Announces Submission of D...
27/07/2020
PharmaCyte Biotech Announces Submission of Drug Master File to FDA for Company’s Pancreatic Cancer Therapy

Great News!! Should be the last piece of business before filing the IND.

>> PharmaCyte Biotech Announces Submission of Drug Master File to FDA for Company’s Pancreatic Cancer Therapy $PMCB #cancer #PancreaticCancer #FDA

PharmaCyte Biotech, Inc., a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ®, announced today that its partner, Austrianova, has submitted a Drug Master File to the U.S. Food and Drug Admin...

Stock Market Media's cover photo
21/05/2020

Stock Market Media's cover photo

PharmaCyte Biotech Receives Medical Devices Registration and Submits Pre-EUA Application to the FDA for COVID-19 Diagnos...
06/05/2020
PharmaCyte Biotech Receives Medical Devices Registration and Submits Pre-EUA Application to the FDA for COVID-19 Diagnostic Kit

PharmaCyte Biotech Receives Medical Devices Registration and Submits Pre-EUA Application to the FDA for COVID-19 Diagnostic Kit https://www.businesswire.com/news/home/20200506005343/en/PharmaCyte-Biotech-Receives-Medical-Devices-Registration-Submits

PharmaCyte Biotech receives medical device registration and submits Pre-EUA application to the FDA for COVID-19 diagnostic kit.

PharmaCyte Biotech Completes Medical Manual for IND Filing - PharmaCyte Biotech
04/05/2020
PharmaCyte Biotech Completes Medical Manual for IND Filing - PharmaCyte Biotech

PharmaCyte Biotech Completes Medical Manual for IND Filing - PharmaCyte Biotech

LAGUNA HILLS, CA May 4, 2020 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has completed a medic...

PharmaCyte Biotech Successfully Completes Pyrogenicity Testing
27/04/2020
PharmaCyte Biotech Successfully Completes Pyrogenicity Testing - PharmaCyte Biotech

PharmaCyte Biotech Successfully Completes Pyrogenicity Testing

LAGUNA HILLS, CA, April 27, 2019 (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has successfully comp...

PharmaCyte Biotech Receives Certificates of Analysis and Batch Records for its Clinical Trial Product in Pancreatic Canc...
12/02/2020
PharmaCyte Biotech Receives Certificates of Analysis and Batch Records for its Clinical Trial Product in Pancreatic Cancer - PharmaCyte Biotech

PharmaCyte Biotech Receives Certificates of Analysis and Batch Records for its Clinical Trial Product in Pancreatic Cancer - PharmaCyte Biotech

LAGUNA HILLS, CA February 12, 2020 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has received th...

Address


Alerts

Be the first to know and let us send you an email when Stock Market Media posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Stock Market Media:

Tell Your Company’s Story

Stock Market Media Group is a content development investor relations firm engaged in shaping, telling and publishing corporate stories in an effort to help companies grow their footprint, gain exposure and build their investor base. At the same time, our goal is to inform investors and attract both retail and institutional investors to newer and smaller companies in the publicly traded markets. We provide companies with a number of avenues to connect with the market--whether it be through feature news articles, corporate videos, research reports, press releases, or CEO interviews--we’re delivering content that helps publicly traded companies inform current and potential new shareholders in the market about their story and their company.